Elanco Animal Health (ELAN) EBIT (2017 - 2025)
Historic EBIT for Elanco Animal Health (ELAN) over the last 9 years, with Q3 2025 value amounting to $167.0 million.
- Elanco Animal Health's EBIT rose 14925.37% to $167.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $85.0 million, marking a year-over-year increase of 10529.27%. This contributed to the annual value of -$1.5 billion for FY2024, which is 5153.55% up from last year.
- According to the latest figures from Q3 2025, Elanco Animal Health's EBIT is $167.0 million, which was up 14925.37% from $221.0 million recorded in Q2 2025.
- Over the past 5 years, Elanco Animal Health's EBIT peaked at $249.0 million during Q1 2025, and registered a low of -$1.6 billion during Q3 2023.
- For the 5-year period, Elanco Animal Health's EBIT averaged around -$457.3 million, with its median value being -$516.0 million (2022).
- In the last 5 years, Elanco Animal Health's EBIT crashed by 20697.67% in 2023 and then soared by 14950.3% in 2025.
- Quarter analysis of 5 years shows Elanco Animal Health's EBIT stood at -$635.0 million in 2021, then grew by 15.43% to -$537.0 million in 2022, then decreased by 19.74% to -$643.0 million in 2023, then rose by 14.15% to -$552.0 million in 2024, then surged by 130.25% to $167.0 million in 2025.
- Its EBIT stands at $167.0 million for Q3 2025, versus $221.0 million for Q2 2025 and $249.0 million for Q1 2025.